LabStyle Innovations to Hold Investor Update Conference Call On Thursday, April 17, 2014
PR Newswire - Thu Apr 10, 3:05PM CDT
LabStyle Innovations Corp. (OTCQB
LabStyle Innovations Announces Partnership With Leading Global Nutrition Data Source For Its Dario Blood Glucose Monitoring Device
PR Newswire - Wed Apr 09, 6:15AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced a partnership with the world's leading global nutrition data application, FatSecret.
Renowned Diabetes Authority Dr. William Polonsky Joins LabStyle Innovations Medical/Scientific Advisory Board
PR Newswire - Wed Apr 02, 6:15AM CDT
LabStyle Innovations Corp. (OTCQB
IPOs and Transactions: March 17 - 21
PR Newswire - Mon Mar 24, 11:30AM CDT
There were 56 transactions filed with the SEC last week. Highlighted corporations and law firms include:
LabStyle Innovations Unveils Dario(TM) - The World's First Personalized Smart Meter
PR Newswire - Tue Mar 11, 11:53AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today revealed the world's first personalized smart meter at the 26th Annual Roth Conference at the Ritz Carlton in Dana Point California.
LabStyle Innovations, Creator of Dario(TM) Diabetes mHealth Solution, to present at the 26th Annual Roth Conference on March 11, 2014
PR Newswire - Thu Mar 06, 3:01PM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes mHealth Solution, today announced that its president and chief executive officer, Mr. Erez Rafael, will be presenting at the 26th Annual Roth Conference. The presentation is scheduled for Tuesday, March 11, 2014 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) at the Ritz Carlton, Laguna Niguel, California.
LabStyle Innovations Announces 2013 Year End Results and Highlights Key Achievements and Anticipated 2014 Milestones
PR Newswire - Wed Mar 05, 6:15AM CST
LabStyle Innovations Corp. (OTCQB/OTCBB: DRIO), developer of the Dario(TM) Diabetes Management Solution, reported today its financial and operational results for the year ended December 31, 2013. The company also presented an overview of recent corporate achievements and anticipated milestones for 2014.
LabStyle Innovations Closes Private Placement Financing
PR Newswire - Thu Feb 20, 6:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has successfully closed its previously announced $4.19 million common stock and warrant private placement financing that priced on February 13, 2014.
LabStyle Innovations Announces Pricing of $4.19 Million Private Placement Financing
PR Newswire - Thu Feb 13, 8:52AM CST
LabStyle Innovations Corp. (OTCQB
LabStyle Innovation Signs Agreement with uHealth to Exclusively Distribute the Dario(TM) Blood Glucose Monitoring Device in Australia
PR Newswire - Tue Feb 04, 6:00AM CST
LabStyle Innovations Corp. (OTCQB
LabStyle President and CEO Erez Raphael to Present and Demonstrate Dario(TM) at the Biotech Showcase 2014 in San Francisco, January 13, 2014 at 8:30 a.m.
Business Wire - Wed Jan 08, 5:59AM CST
LabStyle Innovations Corp. (OTCQB
LabStyle Innovations Files 510(k) in the U.S. for FDA Clearance of the Dario(TM) Blood Glucose Monitoring System
PR Newswire - Tue Jan 07, 6:00AM CST
LabStyle Innovations Corp. (OTCQB
Diabetes Advocate and Opinion Leader David Edelman Joins LabStyle Innovations as Product Strategy Director
PR Newswire - Wed Dec 18, 6:00AM CST
LabStyle Innovations Corp. (OTCQB
LabStyle Innovations Commences World Roll-Out of the Dario(TM) Diabetes Management Platform with Market Launch of iOS App in the United Kingdom, New Zealand and Australia
PR Newswire - Thu Dec 12, 6:00AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of Dario(TM), a cloud-based, mobile health (mHealth) platform for diabetes and related blood glucose monitoring, announced that the world roll-out of the Dario(TM) diabetes management platform is now in progress with today's market launch of the Dario(TM) iOS app in the United Kingdom, New Zealand and Australia.
LabStyle Innovations Appoints Mr. Gadi Levin as Chief Financial Officer
PR Newswire - Wed Nov 27, 11:00AM CST
LabStyle Innovations Corp. (OTCQB
LabStyle Innovations Signs InnoMed to Exclusively Distribute the Dario(TM) Diabetes Management Platform's Blood Glucose Monitoring Device in New Zealand
PR Newswire Europe - Tue Nov 19, 8:28AM CST
RAMAT GAN, Israel, November 19, 2013 /PRNewswire/ --
LabStyle Innovations Welcomes Dennis M. McGrath to its Board of Directors
PR Newswire - Thu Nov 14, 6:00AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of Dario(TM), a cloud-based, mobile health (mHealth) platform for diabetes and related blood glucose monitoring, announced today that medical device industry expert Dennis M. McGrath has joined the company's Board of Directors.
LabStyle Innovations Reports Third Quarter 2013 Results And Provides Business Update
PR Newswire - Tue Nov 12, 7:19AM CST
LabStyle Innovations Corp. (OTCQB/OTCBB: DRIO), developer of Dario(TM), a cloud-based, mobile health (mHealth) platform for diabetes management and related blood glucose monitoring, reported today its financial and operational results for the three and nine months ending on September 30, 2013. The company also provided a business update and its plans for the coming months.
LabStyle Innovations Announces that the European Market Launch of the Dario(TM) Diabetes Management Platform iOS Mobile App Will Begin on December 12, 2013
PR Newswire - Mon Nov 04, 6:00AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of Dario(TM), a cloud-based, mobile health (mHealth) platform for diabetes and related blood glucose monitoring, announced today the official European launch date for the Dario(TM) iOS mobile application.